tiprankstipranks
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD

ACADIA Pharmaceuticals (ACAD) Stock Investors

2,140 Followers
Based on 729,985 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ACAD
On average, investors allocate 3.39% of their portfolios to ACAD
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ACAD

3.7%
Last 7
Days
10.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ACAD, out of 729,985 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ACAD Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.01%
$23.20
Opened
0.73%
$27.17
Opened
0.50%
$23.52
Increased
0.01%
$22.12
Based on the activity of 13,711 investors who made their portfolios public
The table shows changes in ACAD in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ACAD Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.47%
-1.22%
-8.10%
46.31B
Technology
Arista Networks
4.14%
-1.09%
-5.71%
78.53B
Technology
Micron
5.69%
+0.45%
+8.82%
124.53B
Technology
Merck & Company
4.14%
-0.03%
-1.06%
321.34B
Healthcare
Salesforce
4.96%
+0.10%
+0.20%
268.38B
Technology
Qualcomm
4.80%
-0.75%
-6.25%
180.07B
Technology
GE Aerospace
5.47%
+2.12%
+7.19%
177.79B
Industrials
Cisco Systems
4.54%
-0.34%
-4.83%
195.66B
Technology
Trade Desk
4.61%
-0.37%
-4.72%
39.64B
Technology
International Business Machines
5.78%
+1.48%
+5.80%
167.02B
Technology
Based on the activity of 729,985 active portfolios
Open your Smart Portfolio

ACAD Investor Analysis

ACAD investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.5%
of ACAD holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
ACAD investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
57.1%
of ACAD holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
ACAD investors over 55

Over 55

26.0%
Last 30 days
Holdings Change
29.4%
of ACAD holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of ACAD stock investors
See who invests in ACAD according to age group and performance.

FAQ

How many retail Investors hold ACAD?
<0.1% of TipRanks' retail investors hold ACAD in their portfolios.
    What is ACAD Investor Sentiment?
    ACAD’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ACAD in the last 7 days?
      ▼ 3.7% of TipRanks' retail investors changed their holding of ACAD in the last 7 days.
        What percentage of retail investors changed their holding of ACAD in the last 30 days?
        ▼ 10.0% of TipRanks' retail investors changed their holding of ACAD in the last 30 days.
          What is the average age of retail investors who hold ACAD?
          The average age of ACAD Holders is between 35–55.
            What other stocks have ACAD investors also bought?
            ACAD Investors also bought SQ, ANET, MU, MRK, CRM, QCOM, GE, CSCO, TTD, IBM.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis